retatrutide trial weight loss results π¨ HOT OFF THE PRESS: Phase 3 data has arrived β and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Retatrutide approval: FDA status, clinical
Description
After 8 weeks of treatment, tirzepatide significantly reduced fasting plasma glucose levels, HbA1c levels (a measure of long-term blood sugar control), and body weight compared to the placebo

B.JacobsenS

10.1038/s41591-023-02344-1 26 GarberA.HenryR.RatnerR.Garcia-HernandezP

GLP-1 Shots in West Virginia Prescription-based GLP-1 shots across West Virginia, handled online: a short eligibility check, a weekly shot, and discreet home delivery, statewide

Coverage for weight loss alone may be more limited or denied, depending on the plan

E.FarkasI.AnestenF.AnderbergR